HistoWiz, a biotech startup that automates histology by building an intelligent tissue platform for cancer researchers, presented its winning business idea and was named the global winner of the [email protected] Cloud Startup Contest (CACSC). This was a highly competitive event with the finalists from 25 regional contests across China and international markets including Europe, Asia, the Middle East and the United States. The solutions offered by the finalists ranged from big data, artificial intelligence, new retail to smart devices.
Following an intensive pitch process, HistoWiz impressed judges with their business concepts and great commercial potential. From inception in 2013, the company now has over 1,000 paying customers from top academic institutions and pharmaceutical companies around the world, and has accumulated the world’s largest online pathology database with access to a growing network of top pathologists.
“We are thrilled to win the 2017 [email protected] Cloud Startup Contest global championship. Winning this competition will help us enter the Chinese market and partner with local hospitals to provide automated histology service and pathology expertise to Chinese patients. Our intelligent tissue platform will be hosted on Alibaba Cloud. Alibaba Cloud’s scalable infrastructure will help us process and store hundreds of terabytes of pathology image data which can be used to develop automated cancer diagnostic tools,” said Ke Cheng, Founder and CEO of HistoWiz.